Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Viridian Therapeutics, Inc. (MGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Harwin Peter Evan (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 20,000 options to buy @ $27.67, valued at $553.4k
06/16/2023 4 Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 20,000 options to buy @ $27.67, valued at $553.4k
06/16/2023 4 Kiselak Tomas (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 20,000 options to buy @ $27.67, valued at $553.4k
06/16/2023 4 Morris Arlene (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 20,000 options to buy @ $27.67, valued at $553.4k
06/06/2023 4 Meisner Lara (Chief Legal Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 1,875 shares @ $24.21, valued at $45.4k
Sold 499 shares @ $25.03, valued at $12.5k
Sold 5,126 shares @ $25.02, valued at $128.3k
Exercised 1,875 options to buy @ $14, valued at $26.3k
Exercised 499 options to buy @ $18.51, valued at $9.2k
Exercised 5,126 options to buy @ $18.51, valued at $94.9k
03/13/2023 4 Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Bought 5,500 shares @ $29.1499, valued at $160.3k
03/10/2023 4 Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 29,971 shares @ $29.07, valued at $871.3k
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2023 4 Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 250,000 shares @ $0
Granted 1,000,000 options to buy @ $35.8, valued at $35.8M
02/07/2023 3 Myers Scott Dunseth (CEO) has filed a Form 3 on Viridian Therapeutics, Inc.\DE
02/07/2023 4/A Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 50,000 shares @ $36.8, valued at $1.8M
Exercised 50,000 options to buy @ $0.15, valued at $7.5k
02/03/2023 4 Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 50,000 shares @ $36.8, valued at $1.8M
01/25/2023 4 Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 6,843 shares @ $35.66, valued at $244k
Exercised 4,971 options to buy @ $23.03, valued at $114.5k
Exercised 1,872 options to buy @ $14, valued at $26.2k
01/18/2023 4 Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 4,147 shares @ $37.01, valued at $153.5k
Sold 24,853 shares @ $37.21, valued at $924.8k
Exercised 4,147 options to buy @ $23.03, valued at $95.5k
Exercised 24,853 options to buy @ $23.03, valued at $572.4k
01/11/2023 4 Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 12,623 shares @ $33.04, valued at $417.1k
Sold 47,377 shares @ $35.3, valued at $1.7M
Exercised 12,623 options to buy @ $23.03, valued at $290.7k
Exercised 47,377 options to buy @ $23.03, valued at $1.1M
12/22/2022 4 Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 600 shares @ $28.07, valued at $16.8k
Sold 16,326 shares @ $29.19, valued at $476.6k
Exercised 600 options to buy @ $23.03, valued at $13.8k
Exercised 16,326 options to buy @ $23.03, valued at $376k
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Bought 425,531 shares @ $23.5, valued at $10M
06/24/2022 3 Melvin Carrie (COO) has filed a Form 3 on Viridian Therapeutics, Inc.\DE
06/10/2022 4 Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Granted 12,500 options to buy @ $12.31, valued at $153.9k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 30,000 shares @ $12.2, valued at $366k
05/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 26,400 shares @ $18.92, valued at $499.5k
Sold 3,600 shares @ $18.93, valued at $68.1k
03/03/2022 4 Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE
Txns: Sold 18,894 shares @ $17.82, valued at $336.7k
Sold 11,106 shares @ $17.36, valued at $192.8k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy